您的当前位置:首页 > 行业数据 > 中国I期伏罗尼布有效提升52周BCVA字母数
图片属性
图片格式:PNG 图片大小:177KB 图片尺寸:1112*650
同报告图片
 / 4
中国I期伏罗尼布有效提升52周BCVA字母数_第1页
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
中国I期伏罗尼布有效提升52周BCVA字母数_第2页
中国I期伏罗尼布有效提升52周BCVA字母数_第3页
中国I期伏罗尼布有效提升52周BCVA字母数_第4页
中国I期伏罗尼布有效提升52周BCVA字母数_第5页
所属报告: 海西新药-2637.HK-港股公司研究报告:仿创双轨推进HXP056有望重塑眼底病用药格局-260702(18页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠